Frazier Life Sciences Management as of March 31, 2022
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 42 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 13.8 | $162M | 8.4M | 19.26 | |
| Phathom Pharmaceuticals (PHAT) | 6.8 | $79M | 5.8M | 13.61 | |
| Mirum Pharmaceuticals (MIRM) | 6.7 | $79M | 3.6M | 22.02 | |
| Sierra Oncology Com New | 6.4 | $75M | 2.3M | 32.05 | |
| Krystal Biotech (KRYS) | 4.9 | $58M | 866k | 66.54 | |
| Imago Biosciences | 4.9 | $57M | 3.0M | 19.27 | |
| Vaxcyte (PCVX) | 4.8 | $56M | 2.3M | 24.15 | |
| Syndax Pharmaceuticals (SNDX) | 4.7 | $56M | 3.2M | 17.38 | |
| Chinook Therapeutics | 3.8 | $44M | 2.7M | 16.36 | |
| Iveric Bio | 3.5 | $41M | 2.4M | 16.83 | |
| Alpine Immune Sciences (ALPN) | 3.2 | $38M | 4.2M | 8.97 | |
| Miragen Therapeutics (VRDN) | 2.7 | $32M | 1.7M | 18.49 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.6 | $31M | 1.4M | 21.95 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.3 | $27M | 604k | 43.88 | |
| Tarsus Pharmaceuticals (TARS) | 2.0 | $24M | 1.4M | 16.82 | |
| Kalvista Pharmaceuticals (KALV) | 2.0 | $23M | 1.6M | 14.74 | |
| Anaptysbio Inc Common (ANAB) | 1.9 | $22M | 900k | 24.74 | |
| Gritstone Oncology Ord (GRTS) | 1.8 | $22M | 5.2M | 4.12 | |
| Cogent Biosciences (COGT) | 1.7 | $20M | 2.7M | 7.49 | |
| Arvinas Ord (ARVN) | 1.6 | $18M | 270k | 67.30 | |
| Tricida | 1.5 | $17M | 2.1M | 8.22 | |
| Silence Therapeutics Ads (SLN) | 1.4 | $17M | 881k | 19.00 | |
| Merus N V (MRUS) | 1.4 | $17M | 629k | 26.44 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.3 | $16M | 3.7M | 4.17 | |
| Passage Bio (PASG) | 1.3 | $16M | 5.0M | 3.10 | |
| Pardes Biosciences | 1.3 | $15M | 2.1M | 7.22 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.3 | $15M | 1.5M | 9.99 | |
| Intellia Therapeutics (NTLA) | 1.3 | $15M | 204k | 72.67 | |
| Sutro Biopharma (STRO) | 1.2 | $15M | 1.8M | 8.22 | |
| Tyra Biosciences (TYRA) | 1.2 | $14M | 1.3M | 10.70 | |
| Replimune Group (REPL) | 1.0 | $12M | 717k | 16.98 | |
| Gracell Biotechnologies Sponsored Ads | 0.7 | $8.0M | 3.4M | 2.33 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $7.0M | 408k | 17.24 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.6 | $6.5M | 952k | 6.83 | |
| Molecular Templates | 0.4 | $4.7M | 1.4M | 3.45 | |
| Essa Pharma Com New (EPIX) | 0.4 | $4.3M | 693k | 6.18 | |
| Aptinyx | 0.4 | $4.3M | 1.9M | 2.27 | |
| Immunovant (IMVT) | 0.3 | $3.2M | 586k | 5.51 | |
| Scholar Rock Hldg Corp (SRRK) | 0.2 | $2.0M | 156k | 12.89 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.2 | $2.0M | 56k | 35.01 | |
| Epizyme | 0.1 | $850k | 739k | 1.15 | |
| Nabriva Therapeutics SHS | 0.0 | $179k | 426k | 0.42 |
